Immune Checkpoint Inhibitors

Name: 온고지신 AI
Author: 머프키치

Immune Checkpoint Inhibitors을(를) 다룬 문헌 10편. 초록 원문과 구조 요약은 무료 계정으로 열람할 수 있습니다.

[Efficacy-enhancing and toxicity-reducing effects of TCM in immune checkpoint inhibitor-based anti-tumor therapy: a review of mechanisms and advances].종설 · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026
Mechanisms of traditional Chinese medicine in enhancing the efficacy and reducing the toxicity of immune checkpoint inhibitors via regulation of the tumor microenvironment and gut microbiota.종설 · Journal of enzyme inhibition and medicinal chemistry · 2026
Traditional Chinese medicine reverses immune checkpoint resistance through lactate metabolic reprogramming in hepatocellular carcinoma: Mechanisms and therapeutic implications.종설 · Journal of ethnopharmacology · 2026
Traditional Chinese medicine as a potential barrier-oriented sensitization strategy for immune checkpoint blockade in microsatellite-stable colorectal cancer: from resistance mechanisms to translational validation.종설 · Frontiers in immunology · 2026
Evaluation of efficacy, safety and underlying mechanism on Traditional Chinese medicine as synergistic agents for cancer immunotherapy: A preclinical systematic review and meta-analysis.체계적 고찰·메타분석 · Journal of ethnopharmacology · 2025
Gegen Qinlian Tablets attenuate immune-related adverse events in NSCLC patients: A multi-center randomized controlled trial in China.무작위 대조 시험 · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
Effects of Bojungikki-Tang on immune response and clinical outcomes in NSCLC patients receiving immune checkpoint inhibitors: a randomized pilot study.무작위 대조 시험 · BMC cancer · 2025
Therapeutic and immunomodulatory effects of Bojungikki-tang on cancer: a scoping review.체계적 고찰·메타분석 · BMC cancer · 2024
Successful treatment of immune-related cystitis by Chai-Ling-Tang (Sairei-To) in a gastric carcinoma patient: Case report and literature review.증례 보고 · Explore (New York, N.Y.) · 2023
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.유형 미상 · Journal for immunotherapy of cancer · 2021

다른 주제 보기 · 학술지별로 보기